Zheng Zhi, Shang Yuxi, Xu Rui, Yan Xiaosheng, Wang Xi, Cai Jun, Bai Zhigang, Liu Xiaoye, Yin Jie, Zhang Jun, Zhang Zhongtao
Department of General Surgery, Beijing Friendship Hospital, Capital Medical University Beijing, China.
Beijing Key Laboratory of Cancer Invasion and Metastasis Research Beijing, China.
Am J Cancer Res. 2022 Jun 15;12(6):2686-2696. eCollection 2022.
Gastric cancer (GC) is a malignant tumor with an adverse health effect worldwide, whereas the underlying mechanism of GC development remains controversial. Identification of biomarkers is critical for the treatment of GC. Increasing evidence demonstrates that protein modification plays a pivotal role in carcinogenesis. USP38 is a member of the ubiquitin-specific protease (USP) family, which promotes protein stability by deubiquitinating the target proteins. In this study, we focused on the effect of USP38 on the GC and explored its underlying mechanism. The Cancer Genome Atlas (TCGA) database was used to evaluate the expression of USP38. AGS and HGC27 cells were treated with siRNA targeting USP38 or plasmids overexpressing USP38 to disturb levels of USP38. Immumohistochemical staining was performed to detect the level of USP38 and FASN. RT-qPCR and Western blotting (WB) were used to analyze the expression of mRNA and protein respectively. CCK8 assay, colony formation, cell migration assay, and cell apoptosis and cell cycle were performed to assess cell proliferation and migration ability. A subcutaneous tumor mice model was carried to verify the effect of USP38 on the GC in vivo. In this research, we found that USP38 was overexpressed in GC tissues, and USP38 contributed to GC cell proliferation, migration and tumorigenesis. Cell cycle and apoptosis were also regulated by USP38. Mechanistically, USP38 interacted with FASN, which resulted in enhanced protein stability of FASN and increased triglyceride production. Furthermore, FASN was critical for GC cell growth, migration and tumor development triggered by USP38 overexpression because its inhibitor orilistat reversed phenotypes in USP38 overexpressed GC cells. Collectively, USP38 overexpression is critical for GC cell growth, migration and tumorigenesis. Targeting FASN with inhibitors could be used as a potential treatment for GC patients with highly expressed USP38.
胃癌(GC)是一种在全球范围内对健康有不良影响的恶性肿瘤,而GC发生发展的潜在机制仍存在争议。生物标志物的鉴定对GC的治疗至关重要。越来越多的证据表明,蛋白质修饰在致癌过程中起关键作用。USP38是泛素特异性蛋白酶(USP)家族的成员,通过去除靶蛋白的泛素来促进蛋白质稳定性。在本研究中,我们聚焦于USP38对GC的影响并探索其潜在机制。利用癌症基因组图谱(TCGA)数据库评估USP38的表达。用靶向USP38的小干扰RNA(siRNA)或过表达USP38的质粒处理AGS和HGC27细胞,以干扰USP38水平。进行免疫组织化学染色以检测USP38和脂肪酸合酶(FASN)的水平。分别用逆转录-定量聚合酶链反应(RT-qPCR)和蛋白质免疫印迹法(WB)分析mRNA和蛋白质的表达。进行细胞计数试剂盒-8(CCK8)检测、集落形成、细胞迁移检测以及细胞凋亡和细胞周期检测,以评估细胞增殖和迁移能力。建立皮下肿瘤小鼠模型以在体内验证USP38对GC的影响。在本研究中,我们发现USP38在GC组织中过表达,且USP38促进GC细胞增殖、迁移和肿瘤发生。细胞周期和凋亡也受USP38调控。机制上,USP38与FASN相互作用,导致FASN的蛋白质稳定性增强以及甘油三酯生成增加。此外,FASN对USP38过表达引发的GC细胞生长、迁移和肿瘤发展至关重要,因为其抑制剂奥利司他可逆转USP38过表达的GC细胞中的表型。总之,USP38过表达对GC细胞生长、迁移和肿瘤发生至关重要。用抑制剂靶向FASN可作为USP38高表达的GC患者的一种潜在治疗方法。